Abstract
The mitogen-activated protein kinase (MAPK) p38α is a key regulator in many cellular processes, whose activity is tightly regulated by upstream kinases, phosphatases and other regulators. Transforming growth factor-β activated kinase 1 (TAK1) is an upstream kinase in p38α signaling, and its full activation requires a specific activator, the TAK1-binding protein (TAB1). TAB1 was also shown to be an inducer of p38α’s autophosphorylation and/or a substrate driving the feedback control of p38α signaling. Here we determined the complex structure of the unphosphorylated p38α and a docking peptide of TAB1, which shows that the TAB1 peptide binds to the classical MAPK docking groove and induces long-range conformational changes on p38α. Our structural and biochemical analyses suggest that TAB1 is a reasonable substrate of p38α, yet the interaction between the docking peptide and p38α may not be sufficient to trigger trans-autophosphorylation of p38α.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Tanno M, Bassi R, Gorog D A, et al. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res, 2003, 93: 254–261
Kyriakis J M, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev, 2001, 81: 807–869
Qi M, Elion E A. MAP kinase pathways. J Cell Sci, 2005, 118: 3569–3572
Enslen H, Brancho D M, Davis R J. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J, 2000, 19: 1301–1311
Ge B, Gram H, Di Padova F, et al. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science, 2002, 295: 1291–1294
Salvador J M, Mittelstadt P R, Guszczynski T, et al. Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat Immunol, 2005, 6: 390–395
Tzarum N, Diskin R, Engelberg D, et al. Active mutants of the TCR-mediated p38alpha alternative activation site show changes in the phosphorylation lip and DEF site formation. J Mol Biol, 2011, 405: 1154–1169
Gills J J, Castillo S S, Zhang C, et al. Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3/6-independent and -dependent mechanisms. J Biol Chem, 2007, 282: 27020–27029
Tzarum N, Eisenberg-Domovich Y, Gills J J, et al. Lipid molecules induce p38alpha activation via a novel molecular switch. J Mol Biol, 2012, 424: 339–353
Hanafusa H, Ninomiya-Tsuji J, Masuyama N, et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem, 1999, 274: 27161–27167
Yu Y, Ge N, Xie M, et al. Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression. J Biol Chem, 2008, 283: 24497–24505
Singhirunnusorn P, Suzuki S, Kawasaki N, et al. Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J Biol Chem, 2005, 280: 7359–7368
Kishimoto K, Matsumoto K, Ninomiya-Tsuji J. TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J Biol Chem, 2000, 275: 7359–7364
Kumphune S, Chattipakorn S, Chattipakorn N. Role of p38 inhibition in cardiac ischemia/reperfusion injury. Eur J Clin Pharmacol, 2012, 68: 513–524
Denise Martin E, De Nicola G F, Marber M S. New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease. Circulation, 2012, 126: 357–368
Ohkusu-Tsukada K, Tominaga N, Udono H, et al. Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation. Mol Cell Biol, 2004, 24: 6957–6966
Ota A, Zhang J, Ping P, et al. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte. Circ Res, 2010, 106: 1404–1412
Cheung P C, Campbell D G, Nebreda A R, et al. Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. EMBO J, 2003, 22: 5793–5805
Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Macromol Crystallogr Part A, 1997, 276: 307–326
McCoy A J, Grosse-Kunstleve R W, Storoni L C, et al. Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr, 2005, 61: 458–464
Adams P D, Grosse-Kunstleve R W, Hung L W, et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr, 2002, 58: 1948–1954
Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr, 2004, 60: 2126–2132
Laskowski R A, Macarthur M W, Moss D S, et al. Procheck—a program to check the stereochemical quality of protein structures. J Appl Crystallogr, 1993, 26: 283–291
Gaestel M, Kotlyarov A, Kracht M. Targeting innate immunity protein kinase signalling in inflammation. Nat Rev Drug Discov, 2009, 8: 480–499
Cuadrado A, Nebreda A R. Mechanisms and functions of p38 MAPK signalling. Biochem J, 2010, 429: 403–417
Sakurai H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol Sci, 2012, 33: 522–530
Zhou H, Zheng M, Chen J, et al. Determinants that control the specific interactions between TAB1 and p38alpha. Mol Cell Biol, 2006, 26: 3824–3834
Goldsmith E J, Akella R, Min X, et al. Substrate and docking interactions in serine/threonine protein kinases. Chem Rev, 2007, 107: 5065–5081
Chang C I, Xu B E, Akella R, et al. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol Cell, 2002, 9: 1241–1249
Garai A, Zeke A, Gogl G, et al. Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove. Sci Signal, 2012, 5: ra74
Wilson K P, Fitzgibbon M J, Caron P R, et al. Crystal structure of p38 mitogen-activated protein kinase. J Biol Chem, 1996, 271: 27696–27700
Wang Z, Harkins P C, Ulevitch R J, et al. The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. Proc Natl Acad Sci USA, 1997, 94: 2327–2332
Zhang Y Y, Wu J W, Wang Z X. Mitogen-activated protein kinase (MAPK) phosphatase 3-mediated cross-talk between MAPKs ERK2 and p38alpha. J Biol Chem, 2011, 286: 16150–16162
Taylor S S, Kornev A P. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci, 2011, 36: 65–77
Huse M, Kuriyan J. The conformational plasticity of protein kinases. Cell, 2002, 109: 275–282
Nolen B, Taylor S, Ghosh G. Regulation of protein kinases: controlling activity through activation segment conformation. Mol Cell, 2004, 15: 661–675
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Xin, F., Wu, J. Crystal structure of the p38α MAP kinase in complex with a docking peptide from TAB1. Sci. China Life Sci. 56, 653–660 (2013). https://doi.org/10.1007/s11427-013-4494-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-013-4494-0